Trans-arterial embolization of dural arteriovenous fistula using ONYX liquid embolic system. multi-center, prospective registry trial
Phase 3
Recruiting
- Conditions
- dural arteriovenous fistula
- Registration Number
- JPRN-UMIN000013143
- Lead Sponsor
- Kobe City Medical Center General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 22
Inclusion Criteria
Not provided
Exclusion Criteria
1. not indicated for intravenous heparin 2. difficult to follow-up for 6 months 3. allergy for iodine contrast 4. allergy for tantalum
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method curative occlusion of dural arteriovenous fistula at 6 month after embolization
- Secondary Outcome Measures
Name Time Method 1. recanalization of target lesion at 6 months after embolization 2. repeat embolization for recanalization of target lesion at 6 months after embolization 3. stroke due to recanalization of target lesion at 6 months after embolization 4. any cause of death within 6 month after embolization 5. any cause of stroke at 6 month after embolization 6. neurological deterioration at 6 month after embolization 7. modified Rankin Scale at 6 month after embolization